Reasons for Nonattendance across the Hepatitis C Disease Course

This descriptive qualitative study examined the patient, provider, and institutional factors contributing to nonattendance for hepatitis C (HCV) care throughout the disease course. Eighty-four patients and health and social care providers were interviewed. Thematic analysis of the data yielded 6 int...

Full description

Saved in:
Bibliographic Details
Published inISRN nursing Vol. 2013; pp. 579529 - 10
Main Authors Butt, Gail, McGuinness, Liza, Buller-Taylor, Terri, Mitchell, Sandi
Format Journal Article
LanguageEnglish
Published Egypt Hindawi Publishing Corporation 2013
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This descriptive qualitative study examined the patient, provider, and institutional factors contributing to nonattendance for hepatitis C (HCV) care throughout the disease course. Eighty-four patients and health and social care providers were interviewed. Thematic analysis of the data yielded 6 interrelated nonattendance themes: self-protection, determining the benefits, competing priorities, knowledge gaps, access to services, and restrictive policies. Factors within the themes varied with the disease course, type of provider/service, and patient context. Nonattendance could span months to years and most frequently began at diagnosis where providers either advised that followup was not necessary or did not recommend any followup. The way services were organized (low barrier access) and delivered (nonjudgmental approach) and higher HCV knowledge levels of patients and providers encouraged attendance. This is the first study to explore the reasons for nonattendance for HCV care throughout the disease course and validate them from multiple perspectives. There are missed opportunities for providers to encourage attendance throughout the disease course beginning at diagnosis. Interventions required include development of integrated health and social service delivery models; mechanisms to improve knowledge dissemination of the disease, its management, and treatment; and implementation of standardized followup protocols for liver disease monitoring in primary care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Academic Editors: A. Kenny and H. Rhee
ISSN:2090-5483
2090-5491
2090-5491
DOI:10.1155/2013/579529